Scavenger receptor A: A new route for adenovirus 5

Molecular Pharmaceutics

Volumn 6, Issue 2, 2009, Pages 366-374

  Haisma, Hidde J ^a,e   Boesjes, Marije ^a   Beerens, Antoine M ^a   Van Der Strate, Barry W A ^b   Curiel, David T ^c   Plüddemann, Annette ^d   Gordon, Siamon ^d   Bellu, Anna Rita ^a,e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Dept of Therapeutic Gene Modulation ^*  (Netherlands)

Author keywords

Adenovirus; Degradation; Gene therapy; Kupffer cells; Scavenger receptor A

Indexed keywords

ADENOVIRUS VECTOR; SCAVENGER RECEPTOR A;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TRANSGENE; VIRUS ENTRY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; GENETIC VECTORS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER FUNCTION TESTS; MACROPHAGES; MICE; MICE, INBRED C57BL; POLY I; RECEPTORS, SCAVENGER; TRANSFECTION; TRANSGENES;

EID: 64649094821     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp8000974     Document Type: Article

References (53)

1. Bergelson, J. M.; Cunningham, J. A.; Droguett, G.; Kurt-Jones, E. A.; Krithivas, A.; Hong, J. S.; Horwitz, M. S.; Crowell, R. L.; Finberg, R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275, 1320-1323.
2. Tomko, R. P.; Xu, R.; Philipson, L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 3352-3356.
3. Dechecchi, M. C.; Tamanini, A.; Bonizzato, A.; Cabrini, G. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 2000, 268, 382-390.
4. Dechecchi, M. C.; Melotti, P.; Bonizzato, A.; Santacatterina, M.; Chilosi, M.; Cabrini, G. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 2001, 75, 8772-8780.
5. Hong, S. S.; Karayan, L.; Tournier, J.; Curiel, D. T.; Boulanger, P. A. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 1997, 16, 2294-2306.
6. Chu, Y.; Heistad, D.; Cybulsky, M. I.; Davidson, B. L. Vascular cell adhesion molecule-1 augments adenovirus-mediated gene transfer. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 238-242.
7. Wickham, T. J.; Mathias, P.; Cheresh, D. A.; Nemerow, G. R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 75, 309-319.
8. Wickham, T. J. Targeting adenovirus. Gene Ther. 2000, 7, 110-114.
9. Medina-Kauwe, L. K. Endocytosis of adenovirus and adenovirus capsid proteins. Adv. Drug Delivery Rev. 2003, 55, 1485-1496.
10. Lieber, A.; He, C. Y.; Meuse, L.; Schowalter, D.; Kirillova, I.; Winther, B.; Kay, M. A. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 1997, 71, 8798-8807.
11. Manickan, E.; Smith, J. S.; Tian, J.; Eggerman, T. L.; Lozier, J. N.; Muller, J.; Byrnes, A. P. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol. Ther. 2006, 13, 108-117.
12. Schiedner, G.; Bloch, W.; Hertel, S.; Johnston, M.; Molojavyi, A.; Dries, V.; Varga, G.; van, R. N.; Kochanek, S. A hemody- namic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells. Hum. Gene Ther. 2003, 14, 1631-1641.
13. Wolff, G.; Worgall, S.; van, R. N.; Song, W. R.; Harvey, B. G.; Crystal, R. G. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 1997, 71, 624-629.
14. Alemany, R.; Suzuki, K.; Curiel, D. T. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 2000, 81, 2605-2609.
15. Tao, N.; Gao, G. P.; Parr, M.; Johnston, J.; Baradet, T.; Wilson, J. M.; Barsoum, J.; Fawell, S. E. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol. Ther. 2001, 3, 28-35.
16. Zhang, Y.; Chirmule, N.; Gao, G. P.; Qian, R.; Croyle, M.; Joshi, B.; Tazelaar, J.; Wilson, J. M. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther. 2001, 3, 697-707.
17. Worgall, S.; Wolff, G.; Falck-Pedersen, E.; Crystal, R. G. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 1997, 8, 37-44.
18. Muruve, D. A.; Barnes, M. J.; Stillman, I. E.; Libermann, T. A. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 1999, 10, 965-976.
19. Lieber, A.; He, C. Y.; Meuse, L.; Himeda, C.; Wilson, C.; Kay, M. A. Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver. J. Virol. 1998, 72, 9267-9277.
20. Alemany, R.; Curiel, D. T. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 2001, 8, 1347-1353.
21. Smith, T. A.; Idamakanti, N.; Marshall-Neff, J.; Rollence, M. L.; Wright, P.; Kaloss, M.; King, L.; Mech, C.; Dinges, L.; Iverson, W. O.; Sherer, A. D.; Markovits, J. E.; Lyons, R. M.; Kaleko, M.; Stevenson, S. C. Receptor interactions involved in adenoviral- mediated gene delivery after systemic administration in non-human primates. Hum. Gene Ther. 2003, 14, 1595-1604.
22. Smith, T. A.; Idamakanti, N.; Rollence, M. L.; Marshall-Neff, J.; Kim, J.; Mulgrew, K.; Nemerow, G. R.; Kaleko, M.; Stevenson, S. C. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum. Gene Ther. 2003, 14, 777-787.
23. Martin, K.; Brie, A.; Saulnier, P.; Perricaudet, M.; Yeh, P.; Vigne, E. Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol. Ther. 2003, 8, 485-494.
24. Mizuguchi, H.; Koizumi, N.; Hosono, T.; Ishii-Watabe, A.; Uchida, E.; Utoguchi, N.; Watanabe, Y.; Hayakawa, T. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber- modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther. 2002, 9, 769-776.
25. Liu, Q.; Zaiss, A. K.; Colarusso, P.; Patel, K.; Haljan, G.; Wickham, T. J.; Muruve, D. A. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum. Gene Ther. 2003, 14, 627-643.
26. Shayakhmetov, D. M.; Li, Z. Y.; Ni, S.; Lieber, A. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 2004, 78, 5368-5381.
27. Shayakhmetov, D. M.; Gaggar, A.; Ni, S.; Li, Z. Y.; Lieber, A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 2005, 79, 7478-7491.
28. Parker, A. L.; Waddington, S. N.; Nicol, C. G.; Shayakhmetov, D. M.; Buckley, S. M.; Denby, L.; Kemball-Cook, G.; Ni, S.;
29. Lieber, A.; McVey, J. H.; Nicklin, S. A.; Baker, A. H. Multiple vitamin K-dependent coagulation zymogens promote adenovirus- mediated gene delivery to hepatocytes. Blood 2006, 108, 2554-2561.
30. Parker, A. L.; McVey, J. H.; Doctor, J. H.; Lopez-Franco, O.; Waddington, S. N.; Havenga, M. J.; Nicklin, S. A.; Baker, A. H. Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. J. Virol. 2007, 81, 3627-3631.
31. Waddington, S. N.; McVey, J. H.; Bhella, D.; Parker, A. L.; Barker, K.; Atoda, H.; Pink, R.; Buckley, S. M.; Greig, J. A.; Denby, L.; Custers, J.; Morita, T.; Francischetti, I. M.; Monteiro, R. Q.; Barouch, D. H.; van, R. N.; Napoli, C.; Havenga, M. J.; Nicklin, S. A.; Baker, A. H. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008, 152, 397-409.
32. Di Paolo, N. C.; Kalyuzhniy, O.; Shayakhmetov, D. M. Fiber shaft- chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo. J. Virol. 2007, 81, 12249-12259.
33. Othman, M.; Labelle, A.; Mazzetti, I.; Elbatarny, H. S.; Lillicrap, D. Adenovirus-induced thrombocytopenia: the role of von Will- ebrand factor and P-selectin in mediating accelerated platelet clearance. Blood 2007, 109, 2832-2839.
34. Stone, D.; Liu, Y.; Shayakhmetov, D.; Li, Z. Y.; Ni, S.; Lieber, A. Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J. Virol. 2007, 81, 4866-4871.
35. Haisma, H. J.; Kamps, J. A.; Kamps, G. K.; Plantinga, J. A.; Rots, M. G.; Bellu, A. R. Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages. J. Gen. Virol. 2008, 89, 1097-1105.
36. Smith, J. S.; Xu, Z.; Byrnes, A. P. A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells. J. Virol. Methods 2008, 147, 54-60.
37. Krieger, M.; Herz, J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 1994, 63, 601-637.
38. Peiser, L.; Gordon, S. The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect. 2001, 3, 149-159.
39. Pluddemann, A.; Neyen, C.; Gordon, S. Macrophage scavenger receptors and host-derived ligands. Methods 2007, 43, 207-217.
40. Kodama, T.; Freeman, M.; Rohrer, L.; Zabrecky, J.; Matsudaira, P.; Krieger, M. Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils. Nature 1990, 343, 531-535.
41. Rohrer, L.; Freeman, M.; Kodama, T.; Penman, M.; Krieger, M. Coiled-coil fibrous domains mediate ligand binding by macroph- age scavenger receptor type II. Nature 1990, 343, 570-572.
42. Gough, P. J.; Greaves, D. R.; Gordon, S. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J Lipid Res. 1998, 39, 531-543.
43. Ashkenas, J.; Penman, M.; Vasile, E.; Acton, S.; Freeman, M.; Krieger, M. Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J. Lipid Res. 1993, 34, 983-1000.
44. Hamblin, M. R.; Miller, J. L.; Ortel, B. Scavenger-receptor targeted photodynamic therapy. Photochem. Photobiol. 2000, 72, 533-540.
45. Le, L. P.; Everts, M.; Dmitriev, I. P.; Davydova, J. G.; Yamamoto, M.; Curiel, D. T. Fluorescently labeled adenovirus with pIX-EGFP for vector detection. Mol. Imaging 2004, 3, 105-116.
46. Nakano, N.; Fukuhara-Takaki, K.; Jono, T.; Nakajou, K.; Eto, N.; Horiuchi, S.; Takeya, M.; Nagai, R. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE. J. Biochem. 2006, 139, 821-829.
47. Tamanini, A.; Nicolis, E.; Bonizzato, A.; Bezzerri, V.; Melotti, P.; Assael, B. M.; Cabrini, G. Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J. Virol. 2006, 80, 11241-11254.
48. Schiedner, G.; Hertel, S.; Johnston, M.; Dries, V.; van, R. N.; Kochanek, S. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors. Mol. Ther. 2003, 7, 35-43.
49. Haisma, H. J.; Grill, J.; Curiel, D. T.; Hoogeland, S.; van, B. V.; Pinedo, H. M.; Gerritsen, W. R. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther. 2000, 7, 901-904.
50. Bellu, A. R.; Kamps, G. K.; Geel, M.; Kariat, A.; Bouma, A.; Haisma, H. J. Angio-adenobodies are able to target adenovirus to tumor endothelium. Hum. Gene Ther. 2007, 18, 1003.
51. Kamps, J. A.; Morselt, H. W.; Swart, P. J.; Meijer, D. K.; Scherphof, G. L. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 11681-11685.
52. He, T. C.; Zhou, S.; da Costa, L. T.; Yu, J.; Kinzler, K. W.; Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 2509-2514.
53. Becker, T. C.; Noel, R. J.; Coats, W. S.; Gomez-Foix, A. M.; Alam, T.; Gerard, R. D.; Newgard, C. B. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 1994, 43 (Part A), 161-189.